~~<i id='F040F826D6'><strike id='F040F826D6'><tt id='F040F826D6'><pre id='F040F826D6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

author：entertainment 2025-10-01 21:48:03 - browse：76

People waiting in line, standing in between red rope. -- first opinion coverage from STAT — Adobe

Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： After a drawn out lobbying fight, ARPA

entertainment

hotspot

knowledge

explore

AdobeAdealisneverreallydoneuntilit’sdone.OnTuesday,twodifferentproposedinsuranceplanacquisitionsondi

WSS

Researchers tackle phage therapy hurdles for wider adoption

Address the ethical violations that led to 'Three Identical Strangers'

Paxlovid should be available without a positive Covid test

Elevance, SCAN deals highlight health insurer acquisition scrutiny

WHO recommends dropping component of many flu vaccines

Listen: Who gets the credit for GLP

Wikipedia

Wikipedia

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

How to save PrEP access — and even expand it

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Medicare details structure of new drug price negotiation program

FDA warns medical device makers about rise in fabricated data

Peter Hotez and the public health issue of online harassment

Intercept Pharmaceuticals sells itself for less than $1 billion

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

After a drawn out lobbying fight, ARPA

hotspot

Data show record exodus of life scientists from academia

Elevance, SCAN deals highlight health insurer acquisition scrutiny

FDA seeks to regulate lab

Weight loss drugs aren’t covered by Obamacare. That may change

As AI regulations shape up, health tech startups beg for clarity

Inequities make cancer less preventable for women: report

knowledge

explore

explore

explore